Chinese Journal of Schistosomiasis Control ›› 2021, Vol. 33 ›› Issue (5): 540-.

Previous Articles     Next Articles

Progress of researches on the actions of praziquantel against hepatic fibrosis

YUAN Xuan, DAI Jian⁃Rong*   

  1. Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention; Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology; Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China
  • Online:2021-11-02 Published:2021-11-02

吡喹酮抗肝纤维化作用研究进展

袁轩,戴建荣*   

  1. 国家卫生健康委员会寄生虫病预防与控制技术重点实验室、江苏省寄生虫与媒介控制技术重点实验室、江苏省血吸虫病防治研究所(无锡 214064)
  • 作者简介:袁轩,男,硕士研究生。研究方向:血吸虫病防治研究
  • 基金资助:
    国家重点研发计划(2020YFC1200100)

Abstract: Praziquantel not only has broad⁃spectrum anti⁃trematode and anti⁃tapeworm effects, but also has pharmacological effects such as regulating inflammatory response and anti⁃fibrosis. Hereby, the anti⁃fibrosis effect of praziquantel and its mechanism were reviewed in order to provide theoretical basis for the treatment of liver fibrosis.

Key words: Praziquantel, Schistosomiasis, Hepatic fibrosis

摘要: 吡喹酮除具有广谱抗吸虫和绦虫作用外,还具有调节炎症反应、抗纤维化等药理作用。本文综述了吡喹酮抗肝纤维化作用及其机制,以期为吡喹酮用于肝纤维化治疗提供理论依据。 =

关键词: 吡喹酮, 血吸虫病, 肝纤维化

CLC Number: